👉New Article Collection! We are proud to highlight our new article collection, Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program @sirsofficial.bsky.social go.nature.com/495Z3Av

New investigation of what lies behind the 17-year reduction in life expectancy gap between #schizophrenia patients and the general population. 2nd-gen antipsychotics and low frequency hospitalization were associated with reduced mortality @sirsofficial.bsky.social bit.ly/4gdulqF

New paper from our research group presenting important insights from participants about their recovery processes @ginaaas.bsky.social

“Why shouldn’t I expect a lot from life?” Our qual paper on recovery in psychosis is out! Participants reported on their own role in their recovery and the importance of taking positive risks. SFFNORMENT @unioslo-svfak.bsky.social @kristinwold.bsky.social doi.org/10.1186/s128...

New pathways for preventing schizophrenia: public and private partners collaborate in the international Accelerating Medicines Partnership® Schizophrenia consortium @sirsofficial.bsky.social go.nature.com/3Y89zks

It was great to have the possibility to present results from our long-term follow-up study of First Episode Psychosis patients at #SIRS2025 with such great colleagues ♥️ @sirsofficial.bsky.social

Keynote on digital interventions for psychosis: Mario Alvarez-Jimenez kicking off day 3 @ #SIRS2025 @sirsofficial.bsky.social with powerful images on the omnipresence of technology in our daily lives - before elegantly demonstrating how this could be exploited to address current treatment challenges

Great symposium on self-disorders in schizophrenia at #SIRS2025 (@sirsofficial.bsky.social), spearheaded by @jfeyaerts.bsky.social, with exciting empirical findings presented by @ccrosenphd.bsky.social (20-year follow-up!) and Julia Lebovitz, and a stimulating discussion by Louis Sass.

Looking forward to participate at the #SIRS2025 conference!

Cognition is a core biomarker for schizophrenia & key focus in the Accelerating Medicines Partnership® (AMP SCZ) initiative. Here the authors outline the rationale and harmonization of the cognitive battery @kelly_allott @Wal_yas @ @scottwoods01.bsky.social @patmcgorry.bsky.social bit.ly/4iWAFmA

Proud to be part of my wonderful colleague @ginaaas important contribution on what patients describe as important in their recoveryprocess from First-Episode Psychosis ♥️ @SFFNORMENT @UniOslo_MED @Oslounivsykehus @i_s_melle